{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:19:40Z","timestamp":1753888780797},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"S12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1007\/bf02087888","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:36:04Z","timestamp":1124019364000},"page":"126S-130S","source":"Crossref","is-referenced-by-count":12,"title":["Interferon-\u03b1 therapy for chronic hepatitis C in special patient populations"],"prefix":"10.1007","volume":"41","author":[{"given":"Patrick","family":"Marcellin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Behamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Erlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02087888_CR1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.1840220406","volume":"22","author":"M Martinot-Peignoux","year":"1995","unstructured":"Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050\u20131056, 1995","journal-title":"Hepatology"},{"key":"BF02087888_CR2","first-page":"1137","volume":"20","author":"C F\u00e9ray","year":"1994","unstructured":"F\u00e9ray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Reynes M, Urdea M, Br\u00e9chot C, Bismuth H: The course of hepatitis C infection after liver transplantation. Hepatology 20:1137\u20131143, 1994","journal-title":"Hepatology"},{"key":"BF02087888_CR3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0016-5085(89)90405-8","volume":"97","author":"P Martin","year":"1989","unstructured":"Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH: Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97:1559\u20131561, 1989","journal-title":"Gastroenterology"},{"key":"BF02087888_CR4","first-page":"1495","volume":"1","author":"CRM Hay","year":"1985","unstructured":"Hay CRM, Preston FE, Triger DR, Underwood JCE: Progressive liver disease in haemophilia: An understated problem? Lancet 1:1495\u20131498, 1985","journal-title":"Lancet"},{"key":"BF02087888_CR5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.V66.6.1317.1317","volume":"66","author":"ME Eyster","year":"1985","unstructured":"Eyster ME, Whitehurst DA, Catalano PM, McMillan CW, Goodnight SH, Kasper CK, Gill JC, Aledort LM, Hilgartner MW, Levine PH, Edson JR, Hathaway WE, Lusher JM, Gill FM, Poole WK, Shapiro SS: Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood 66:1317\u20131320, 1985","journal-title":"Blood"},{"key":"BF02087888_CR6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0140-6736(90)91124-S","volume":"335","author":"M Makris","year":"1990","unstructured":"Makris M, Preston FE, Triger DR, Underwood JCE, Choo OL, Kuo G, Houghton M: Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 335:1117\u20131119, 1990","journal-title":"Lancet"},{"key":"BF02087888_CR7","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/blood.V78.7.1672.1672","volume":"78","author":"M Makris","year":"1991","unstructured":"Makris M, Preston FE, Triger DR, Underwood JCE, Westlake L, Adelman MI: A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood 78:1672\u20131677, 1991","journal-title":"Blood"},{"key":"BF02087888_CR8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.1995.198","volume":"47","author":"S Pol","year":"1995","unstructured":"Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Br\u00e9chot C: Efficacy and tolerance of\u03b1-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 47:1412\u20131418, 1995","journal-title":"Kidney Int"},{"key":"BF02087888_CR9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00007890-199204000-00011","volume":"53","author":"C-C Huang","year":"1992","unstructured":"Huang C-C, Liaw Y-F, Lai M-K, Chu S-H, Chuang C-K, Huang J-Y: The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 53:763\u2013765, 1992","journal-title":"Transplantation"},{"key":"BF02087888_CR10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0016-5085(93)91023-B","volume":"104","author":"T-M Chan","year":"1993","unstructured":"Chan T-M, Lok ASF, Cheng IKP, Chan RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104:862\u2013868, 1993","journal-title":"Gastroenterology"},{"key":"BF02087888_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-198802000-00031","volume":"45","author":"J Kovarik","year":"1988","unstructured":"Kovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, Smolen J: Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation 45:402\u2013405, 1988","journal-title":"Transplantation"},{"key":"BF02087888_CR12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00007890-199409150-00018","volume":"58","author":"E Thervet","year":"1994","unstructured":"Thervet E, Pol S, Legendre Ch, Gagnadoux M-F, Cavalcanti R, Kreis H: Low-dose recombinant leukocyte interferon-\u03b1 treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation 58:625\u2013628, 1994","journal-title":"Transplantation"},{"key":"BF02087888_CR13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","volume":"59","author":"L Rostaing","year":"1995","unstructured":"Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durant D: Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 59:1426\u20131431, 1995","journal-title":"Transplantation"},{"key":"BF02087888_CR14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/0016-5085(95)90207-4","volume":"108","author":"C F\u00e9ray","year":"1995","unstructured":"F\u00e9ray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reyn\u00e9s M, Okamoto H, Bismuth H, Br\u00e9chot C: Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108:1088\u20131096, 1995","journal-title":"Gastroenterology"},{"key":"BF02087888_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00007890-199201000-00023","volume":"53","author":"HI Wright","year":"1992","unstructured":"Wright HI, Gavaler JS, Van Thiel DH: Preliminary experience with\u03b1-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 53:121\u2013124, 1992","journal-title":"Transplantation"},{"key":"BF02087888_CR16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00042737-199409000-00007","volume":"6","author":"DH Thiel Van","year":"1994","unstructured":"Van Thiel DH, Baddour N, Fagiuoli S, Wright HI, Gavaler JS: Alpha interferon treatment of hepatitis C in patients with liver allografts treated with either FK-506 or cyclosporin A. Eur J Gastroenterol Hepatol 6:787\u2013791, 1994","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF02087888_CR17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840220411","volume":"22","author":"C F\u00e9ray","year":"1995","unstructured":"F\u00e9ray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reyn\u00e8s M, Bismuth H: An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 22:1084\u20131089, 1995","journal-title":"Hepatology"},{"key":"BF02087888_CR18","first-page":"1627","volume":"59","author":"AC Gadano","year":"1995","unstructured":"Gadano AC, Mosnier J-F, Durand F, Martinot-Peignoux M, Marcellin P, Degott C, Belghiti J, Erlinger S, Benhamou J-P, Bernuau JR:\u03b1-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen. Transplantation 59:1627\u20131629, 1995","journal-title":"Transplantation"},{"issue":"suppl 2","key":"BF02087888_CR19","first-page":"22","volume":"23","author":"T Bizollon","year":"1995","unstructured":"Bizollon T, Ducerf C, Tr\u00e9po C: New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. J Hepatol 23(suppl 2):22\u201325, 1995","journal-title":"J Hepatol"},{"key":"BF02087888_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2007-1007267","volume":"15","author":"RS Koff","year":"1995","unstructured":"Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 15:101\u2013108, 1995","journal-title":"Semin Liver Dis"},{"key":"BF02087888_CR21","first-page":"247","volume-title":"Progress in Liver Diseases, XIII","author":"P Marcellin","year":"1995","unstructured":"Marcellin P, Benhamou JP: Autoimmune disorders associated with hepatitis C.In Progress in Liver Diseases, XIII, Boyer JL, Ockner RK (eds). Philadelphia, WB Saunders Company, 1995, pp 247\u2013267"},{"key":"BF02087888_CR22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0016-5085(93)90862-7","volume":"104","author":"P Marcellin","year":"1993","unstructured":"Marcellin P, Descamps V, Martinot-Peignoux M, Larqu D, Xu L, Boyer N, Pham B-N, Crickx B, Guillevin L, Belaich S, Erlinger S, Benhamou J-P: Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104:272\u2013277, 1993","journal-title":"Gastroenterology"},{"key":"BF02087888_CR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","volume":"330","author":"R Misiani","year":"1994","unstructured":"Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751\u2013756, 1994","journal-title":"N Engl J Med"},{"key":"BF02087888_CR24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","volume":"328","author":"RJ Johnson","year":"1993","unstructured":"Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465\u2013470, 1993","journal-title":"N Engl J Med"},{"key":"BF02087888_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/165.4.723","volume":"165","author":"N Boyer","year":"1992","unstructured":"Boyer N, Marcellin P, Degott C, Degos F, Saimot AG, Erlinger S, Benhamou JP, and the Comit\u00e9 des anti-viraux: Recombinant interferon-a for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J Infect Dis 165:723\u2013726, 1992","journal-title":"J Infect Dis"},{"key":"BF02087888_CR26","unstructured":"Marcellin P, Boyer N, Areias J, Erlinger S, Benhamou JP: Comparison of efficacy of alpha interferon in former intravenous drug addicts with chronic hepatitis C with or without HIV infection. Gastroenterology 106(4 Pt 2):A938, 1994 (abstract)"},{"key":"BF02087888_CR27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00002030-199510000-00003","volume":"9","author":"B Cribier","year":"1995","unstructured":"Cribier B, Rey D, Schmitt C, Lang J-M, Kirn A, Stoll-Keller F: High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131\u20131136, 1995","journal-title":"AIDS"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02087888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02087888\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02087888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:52:37Z","timestamp":1586393557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02087888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":27,"journal-issue":{"issue":"S12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["BF02087888"],"URL":"https:\/\/doi.org\/10.1007\/bf02087888","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}